Metformin Activates AMP Kinase through Inhibition of AMP Deaminase
Open Access
- 1 January 2011
- journal article
- Published by Elsevier BV
- Vol. 286 (1), 1-11
- https://doi.org/10.1074/jbc.m110.121806
Abstract
No abstract availableKeywords
This publication has 65 references indexed in Scilit:
- AMPK and the biochemistry of exercise: implications for human health and diseaseBiochemical Journal, 2009
- Role of AMP‐activated protein kinase in the metabolic syndrome and in heart diseaseFEBS Letters, 2007
- Methyl succinate antagonises biguanide‐induced AMPK‐activation and death of pancreatic β‐cells through restoration of mitochondrial electron transferBritish Journal of Pharmacology, 2007
- Metformin: 50 years old, fit as a fiddle, and indispensable for its pivotal role in type 2 diabetes managementDiabetes & Metabolism, 2006
- LKB1, an upstream AMPK kinase, regulates glucose and lipid metabolism in cultured liver and muscle cellsBiochemical and Biophysical Research Communications, 2006
- Deficiency of LKB1 in skeletal muscle prevents AMPK activation and glucose uptake during contractionThe EMBO Journal, 2005
- Role of AMP-activated protein kinase in mechanism of metformin actionJCI Insight, 2001
- Changes in Ryanodine Receptor‐Mediated Calcium Release During Skeletal Muscle DifferentiationProceedings of the Society for Experimental Biology and Medicine, 1999
- An antibody VH domain with a lox‐Cre site integrated into its coding region: bacterial recombination within a single polypeptide chainFEBS Letters, 1995
- Glucose transport in human skeletal muscle cells in culture. Stimulation by insulin and metformin.JCI Insight, 1992